No biomarker yet guides psychiatric treatment choice.

Unlike guidelines that list options, algorithms specify exact steps — like switching treatment if symptoms don’t improve by 50% within 6 weeks.

The authors argue psychiatry should adopt algorithm-based care despite lacking patient-level biomarkers.

Sources: Nature